Pay in 4 interest-free payments of $7.10 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Compound: Modified GRF 1-29 (CJC-1295 without Drug Affinity Complex) Concentration: 5mg per vial Format: Lyophilized White Powder (Strictly for In-Vitro Laboratory Use) Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Syr-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Sark-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-L-Ser-Arg-NH2 Chemical Classification: Growth Hormone Releasing Hormone (GHRH) Analog Chemical Profile: CJC-1295 (No Dac), frequently referred to in literature as Mod GRF 1-29 , is a tetrasubstituted analogue of the endogenous Growth Hormone Releasing Hormone (GHRH)
But most studies and companies focus on one or the other, which has created some friction in the NAD+ boosting community, between advocates of NMN and advocates of NR
This analysis confirmed that the released protein is TRF1 (Fig
Frequently Asked Questions Q1: Is BPC-157 an approved medical treatment
10.1177/0394632017742224 Int
5-Amino-1MQ and Metabolic Research Researchers studying 5-Amino-1MQ commonly focus on: Obesity research Weight management pathways Energy metabolism Endocrine signaling Adipose tissue studies Cellular metabolic regulation Published preclinical research involving NNMT inhibition has generated increasing interest in metabolic pathway modulation and energy balance studies
US$ 25.87
US$ 25.86
US$ 22.44
US$ 26.63
US$ 27.63